
UBS comments on Palantir's earnings report: the company's "narrative is flawless," raising the target price to $165

I'm PortAI, I can summarize articles.
Palantir previously announced its second-quarter financial report, with revenue increasing by 48% year-on-year, and raised its full-year performance expectations, triggering a strong market reaction. UBS analysts believe that Palantir is experiencing an unprecedented growth inflection point, with rapid growth in its U.S. commercial business, becoming the company's "new core," while its defense business remains strong. However, UBS also pointed out that the company's valuation remains high, with a free cash flow valuation multiple of 136 times, thus maintaining a "neutral" rating
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

